Last updated: February 2025
By checking the consent box during your intake, you confirm that you have read, understood, and agree to the following terms governing your telehealth consultation and hair loss treatment through Dermful.
Telehealth involves the delivery of healthcare services using electronic communications, including the internet, video, phone, and secure messaging. Through Dermful's platform, licensed providers employed or contracted by Beluga Health, P.A. (the "Medical Group") will review your submitted intake information, health history, and supporting documents to evaluate whether prescription hair loss treatment is appropriate for you.
You understand that your consultation will take place asynchronously — meaning your provider will review your information and respond without a real-time video or phone call, unless otherwise arranged.
Submitting an intake form and making a purchase does not guarantee that a prescription will be issued. A licensed provider will independently evaluate your information and may decline to prescribe if, in their professional judgment, treatment is not appropriate for you. If a prescription is not issued, you will be notified and refunded accordingly.
You acknowledge and understand that telehealth has inherent limitations compared to in-person care, including:
The provider cannot perform a physical examination
Certain conditions may not be diagnosable or treatable through telehealth
In emergencies, telehealth is not an appropriate substitute for in-person emergency careIf you are experiencing a medical emergency, call 911 or go to your nearest emergency room immediately.
Do not use this platform for urgent or emergency medical needs.
Your safety depends on the accuracy of the information you provide. By consenting, you verify that you are the patient submitting this intake form. You confirm that you have reviewed and understood all questions asked of you, and that all answers and information you have provided are true and complete to the best of your knowledge.You understand that it is critical to your health to share complete and accurate information with your provider. You agree not to hold the provider or affiliated Medical Group responsible for any adverse outcomes resulting from incomplete, inaccurate, or withheld information you provided.
Purpose of Treatment
The treatments prescribed through Dermful are intended to slow hair loss, stimulate new growth, and improve hair density and appearance. Treatment is tailored to your individual evaluation and may include one or more of the following options.
Treatment Options
Finasteride is an oral medication that blocks the conversion of testosterone to dihydrotestosterone (DHT), a hormone linked to hair loss.
It is available for men and post-menopausal women only, due to the risk of severe birth defects.
Topical finasteride is not FDA-approved but is commonly used in compounded formulations for hair loss.Minoxidil is a topical solution that increases blood flow to the scalp to stimulate hair follicle activity. FDA-approved for topical hair loss use.
When prescribed orally, it is used off-label.GHK-Cu (Copper Peptide Complex) is a topical compound intended to support scalp health, blood flow, and hair growth.
Additional compounded treatments may be prescribed at your provider's discretion, including combinations of anti-inflammatory agents, caffeine derivatives, antihistamines, spironolactone, dutasteride, retinoic acid, or hydrocortisone. Please note that compounded formulations are not FDA-approved.
Potential BenefitsTreatment may help slow the progression of hair loss, stimulate new hair growth, improve hair thickness and density, and support your self-confidence and quality of life. Individual results vary and are not guaranteed. Visible results typically take 3 to 6 months of consistent use.ContraindicationsYou should not proceed with certain treatments if any of the following apply to you.
For Finasteride: liver disease, history of prostate cancer, known allergy to finasteride, or any possibility of pregnancy. Women who are pregnant or may become pregnant must not use or handle finasteride tablets.
For Minoxidil: active scalp conditions such as dermatitis or psoriasis, or known allergy to minoxidil.
For GHK-Cu: known allergy to copper peptides. Generally, no treatments should be used during pregnancy or breastfeeding, or by individuals with unmanaged hormonal imbalances or active scalp sensitivities.
It is your responsibility to disclose all relevant conditions during your intake.
Potential Risks and Side EffectsFinasteride may cause decreased libido, erectile dysfunction, breast tenderness or enlargement, mood changes or depression, allergic reactions, and may affect PSA levels used in prostate cancer screening.
There is a severe risk of birth defects if exposure occurs during pregnancy.Minoxidil may cause scalp irritation, itching or dryness, unwanted facial or body hair growth, and in rare cases changes in blood pressure or heart rate.
GHK-Cu may cause scalp irritation or allergic reactions in sensitive individuals.Across all treatments, general risks may include hormonal changes, electrolyte imbalances, and mood changes.
This list is not exhaustive. Your provider may identify additional risks specific to your health profile.Alternative TreatmentsYou have the right to explore alternatives to the treatments offered through Dermful, including hair transplant surgery, low-level laser therapy (LLLT), platelet-rich plasma (PRP) therapy, over-the-counter topical minoxidil, and lifestyle adjustments.
Your Responsibilities as a PatientYou agree to use all treatments exactly as prescribed, report any side effects to your provider promptly, keep all scheduled follow-up appointments, and inform your provider of any changes in your health status, new medications, or new diagnoses.
Your care is provided by licensed physicians employed or contracted by Beluga Health, P.A., the Medical Group partnered with Dermful. Providers are licensed in the state where you reside at the time of your consultation. Dermful currently serves residents of the United States, excluding Alaska, Louisiana, Mississippi, New Hampshire, New Mexico, Puerto Rico, Guam, the U.S. Virgin Islands, American Samoa, and the Northern Mariana Islands.
You have the right to withdraw this consent and discontinue telehealth services at any time without affecting your right to future care from other providers. To withdraw, contact us at contact@dermful.com. Withdrawal of consent does not entitle you to a refund for prescriptions already dispensed or orders already processed.
Your health information is handled in accordance with Dermful's Privacy Policy. You acknowledge that communications sent via text message or email are not encrypted, and that transmission over the internet and mobile networks is not completely private or secure. By proceeding, you consent to receiving unencrypted communications from Dermful and its affiliated providers regarding your care, prescriptions, and account. If you have concerns about the security of your health information, please contact us before proceeding.
By checking the consent box during your intake, you confirm that you have read and understood this Consent to Telehealth in its entirety. You agree to proceed with a telehealth evaluation under the terms described above, acknowledge the risks and limitations of remote care, and consent to the treatment options outlined herein.For questions, contact us at contact@dermful.com
